TRENTINI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 6.731
EU - Europa 2.462
AS - Asia 2.172
SA - Sud America 174
AF - Africa 25
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 7
Totale 11.584
Nazione #
US - Stati Uniti d'America 6.684
SG - Singapore 957
IT - Italia 754
CN - Cina 683
PL - Polonia 435
DE - Germania 338
UA - Ucraina 264
TR - Turchia 217
GB - Regno Unito 177
BR - Brasile 156
FI - Finlandia 105
ID - Indonesia 100
SE - Svezia 87
HK - Hong Kong 76
BE - Belgio 44
IE - Irlanda 44
CA - Canada 41
FR - Francia 35
NL - Olanda 31
CZ - Repubblica Ceca 30
VN - Vietnam 30
AT - Austria 29
IR - Iran 17
ES - Italia 16
KR - Corea 16
RU - Federazione Russa 15
IN - India 13
LT - Lituania 13
TW - Taiwan 13
IQ - Iraq 11
AU - Australia 10
RO - Romania 9
BG - Bulgaria 7
JP - Giappone 7
MY - Malesia 7
SD - Sudan 7
ZA - Sudafrica 7
PT - Portogallo 6
AR - Argentina 5
MA - Marocco 5
CH - Svizzera 4
CO - Colombia 4
EU - Europa 4
SK - Slovacchia (Repubblica Slovacca) 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EG - Egitto 3
HR - Croazia 3
MX - Messico 3
NP - Nepal 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BD - Bangladesh 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CL - Cile 2
DK - Danimarca 2
EC - Ecuador 2
KZ - Kazakistan 2
PA - Panama 2
PH - Filippine 2
PK - Pakistan 2
TH - Thailandia 2
AZ - Azerbaigian 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
JO - Giordania 1
KE - Kenya 1
LV - Lettonia 1
MD - Moldavia 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
SA - Arabia Saudita 1
TN - Tunisia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 11.584
Città #
Fairfield 776
Woodbridge 701
Ann Arbor 492
Santa Clara 467
Chandler 452
Ashburn 433
Singapore 427
Warsaw 419
Houston 412
Ferrara 320
Jacksonville 316
Seattle 277
Wilmington 260
Cambridge 251
Izmir 157
Beijing 127
Nanjing 121
Princeton 115
Menlo Park 98
Jakarta 91
Shanghai 82
Boardman 75
Milan 75
Hong Kong 71
Bologna 56
Dearborn 55
San Diego 52
Addison 48
Brussels 42
Los Angeles 42
Nanchang 40
Shenyang 40
Helsinki 39
Bremen 37
New York 35
Munich 30
London 28
Dong Ket 27
Falls Church 26
Changsha 25
Brno 24
Tianjin 24
Nuremberg 22
Jiaxing 21
Falkenstein 20
Toronto 20
Hebei 18
Redwood City 18
Vienna 18
St Louis 17
Norwalk 16
Ningbo 15
Orange 15
Frankfurt am Main 14
Washington 14
Guangzhou 12
Jinan 12
Mountain View 12
Rome 11
Auburn Hills 10
Augusta 10
Ottawa 10
São Paulo 10
Hefei 9
Kraków 9
Belo Horizonte 8
Casalecchio Di Reno 8
Chicago 8
Des Moines 8
Leawood 8
Montréal 8
San Mateo 8
Indiana 7
Taizhou 7
Zhengzhou 7
Dublin 6
Ferrara di Monte Baldo 6
Kunming 6
Lappeenranta 6
Taipei 6
Tappahannock 6
The Dalles 6
Cagliari 5
Düsseldorf 5
Kilburn 5
Lauterbourg 5
Lübeck 5
Marigliano 5
Modena 5
Wageningen 5
Amsterdam 4
Baghdad 4
Campinas 4
Clifton 4
Council Bluffs 4
Curitiba 4
Fort Worth 4
Haikou 4
Khartoum 4
Konya 4
Totale 8.217
Nome #
Serum beta-secretase 1 (BACE1) activity as candidate biomarker for late-onset Alzheimer’s disease 239
Gelatinases, Neurofilaments and N-Acetyl aspartic Acid as Biomarkers in Different Pathologies 208
Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study 202
Decreased Arylesterase activity of Paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 183
Influence of Vaginal Lactoferrin Administration on Amniotic Fluid Cytokines and its Role Against Inflammatory Complications of Pregnancy 173
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 172
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 167
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 164
null 163
Low-grade systemic inflammation is associated with functional disability in elderly people affected by dementia 163
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 157
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 156
Extrapulmonary tuberculosis among immigrants in a low-TB burden and high immigrant receiving city of northern Italy 156
Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage 154
Changes in adipose tissue distribution and association between uric acid and bone health during menopause transition 148
Study of the potential influence of obesity on the activities of serum Paraoxonase-1 and lipoprotein-associated phospholipase A2 143
Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women 142
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 141
Leishmania Infantum Cryptic Infection in Immunosuppressed Rheumatologic Patients and Healthy Controls from Northern Italy: Epidemiological Variables That Can Affect Infection Risk 140
Subclinical Leishmania infection in patients with rheumatic diseases under biological drugs 139
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 137
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 136
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 133
TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress 133
Epidemiologia ed Outcome delle Infezioni della Cute e dei Tessuti Molli Osservate a Ferrara nel Quinquennio 2011-2016 132
Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up 132
Mutual relationship between serum ferroxidase activity and hemoglobin levels in elderly individuals 131
Leptin/adiponectin ratio predicts post-stroke neurological outcome 130
null 128
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 126
Serum from patients affected by Alzheimer disease shows a paraoxonase-dependent pro-apoptotic effect on endothelial cells 122
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 121
Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1 120
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 118
Proteomic analysis of 4-hydroxynonenal and nitrotyrosine modified proteins in RTT fibroblasts 117
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 113
Evaluation of a possible role of oxidative stress in climacteric symptoms. 113
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 112
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 111
null 110
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 109
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 108
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 106
null 106
Schematic overview of oligosaccharides, with survey on their major physiological effects and a focus on milk ones 106
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 105
Increased blood BACE1 activity as a potential common pathogenic factor of vascular dementia and late onset Alzheimer's disease 105
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 101
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 99
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 98
Finding peculiar patterns of kinetoplastida enzymes to be exploited in drug design 98
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 98
Sex difference impacts on the relationship between paraoxonase-1 (Pon1) and type 2 diabetes 98
null 97
Testing a Combination of Markers of Systemic Redox Status as a Possible Tool for the Diagnosis of Late Onset Alzheimer's Disease 97
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 97
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 97
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 95
Implication of oxidative stress in dementia: data from cross-sectional and longitudinal study 94
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 93
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 89
Inflammation and axonal damage biomarkers in Multiple Sclerosis: new perspective on their role 89
null 86
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 86
null 85
null 83
Decreased serum PCSK9 levels after ischemic stroke predict worse outcomes 83
A Comparison Between Different Anti-Retroviral Therapy Regimes on Soluble Inflammation Markers: a Pilot Study 83
Arylesterase activity of paraoxonase-1 in serum and cerebrospinal fluid of patients with alzheimer’s disease and vascular dementia 80
null 78
Fluids administration modulate the matrix metalloproteinase-9 (MMP-9), myeloperoxidase (MPO) activities and inflammatory neutrophils response 77
EVALUATION OF THE SWITCH TO A DUAL ART REGIMEN WITH LAMIVUDINE PLUS DOLUTEGRAVIR OR PROTEASE INHIBITORS IN HIV-INFECTED VIROLOGICALLY SUPPRESSED PATIENTS. A REAL LIFE EXPERIENCE 77
Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: Role of MPO specific activity in coronary artery disease 76
Gelatinases: enzymatic activity as potential biomarker in multiple sclerosis 75
Gelatinase: enzymatic activity as potential biomarker in multiple sclerosis 73
Heparin binds Matrix Metalloproteinase-9 (MMP-9): effect on the proteolytic activity 71
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis 71
Matrix metalloproteinase-2 (MMP-2) immune functions via surface proteolytic shedding of HLA-G1 molecules 70
Purification of transglutaminase enzyme from L. infantum promastigotes 68
null 68
Diaphragmatic dysfunction in critically patients undergoing mechanical ventilation 67
Fermentation of Vaccinium floribundum Berries with Lactiplantibacillus plantarum Reduces Oxidative Stress in Endothelial Cells and Modulates Macrophages Function 67
Matrix Metalloprotease-9 activity detected in body fluids is the result of two different enzyme forms 65
Gelatinase A (MMP-2) and B (MMP-9): their active forms as biomarkers in multiple sclerosis 64
Serum Ferroxidase Activity in Patients with Multiple Sclerosis: A Pilot Study 64
Clinical and Laboratory Findings in Tick-Borne Encephalitis Virus Infection 64
Inflammation in Neurological Disorders: The Thin Boundary between Brain and Periphery 64
Extracellular pH modulates the release of Matrix Metalloproteinase-9 (MMP-9) by stimulated neutrophils and its activity. 63
Acute Prosthetic Joint Infections with Poor Outcome Caused by Staphylococcus Aureus Strains Producing the Panton-Valentine Leukocidin 62
Fluids administration can modulate inflammatory neutrophils response and MMP-9 activity: an in vitro study 62
Investigating intra- and extra-cellular functions of Transglutaminase 2 by use of inhibitors with different localization in breast cancer cells 60
Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer’s Disease: Systematic Review and Meta-Analysis 57
The influence of different replacement solutions on neutrophils response 56
MMP-9 isoforms in serum of Multiple Sclerosis patients 54
The sex-specific detrimental effect of diabetes and gender-related factors on pre-admission medication adherence among patients hospitalized for ischemic heart disease: Insights from EVA study 54
Paraoxonase-1 and dementia-related diseases 53
null 49
Brain and serum cholesterol dyshomeostasis during the perimenopausal transition: A possible risk factor for Alzheimer’s disease 49
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 48
Serum beta-secretase 1 (BACE1) activity increases in patients with mild cognitive impairment 48
Totale 10.530
Categoria #
all - tutte 66.998
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.998


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020317 0 0 0 0 0 0 0 0 0 171 86 60
2020/20211.782 106 110 94 154 162 164 102 185 89 310 181 125
2021/20221.247 100 145 155 42 41 75 61 71 37 113 58 349
2022/20231.137 119 104 35 135 174 146 72 111 125 9 65 42
2023/2024864 67 84 37 24 94 98 42 78 44 33 43 220
2024/20252.636 106 98 292 148 442 330 146 211 573 290 0 0
Totale 11.970